Literature DB >> 8923308

Cerebral venous thrombosis and activated protein C resistance.

M Sánchez del Rio, E Gómez-Tortosa, J Outeriño.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923308     DOI: 10.1007/bf00873981

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Human genetics. Bad blood by mutation.

Authors:  P W Majerus
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

2.  Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance.

Authors:  J Emmerich; O Poirier; A Evans; P Marques-Vidal; D Arveiler; G Luc; M Aiach; F Cambien
Journal:  Lancet       Date:  1995-02-04       Impact factor: 79.321

3.  Activated protein C resistance in cases of cerebral infarction.

Authors:  P D Forsyth; G Dolan
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

4.  Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.

Authors:  B Dahlbäck; B Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

5.  Factor V gene mutation is a risk factor for cerebral venous thrombosis.

Authors:  I Martinelli; G Landi; G Merati; R Cella; A Tosetto; P M Mannucci
Journal:  Thromb Haemost       Date:  1996-03       Impact factor: 5.249

6.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

Review 7.  [Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations].

Authors:  M Trossaërt; J Conard; M H Horellou; M Samaha; I Elalamy; M M Samama
Journal:  Presse Med       Date:  1995-01-28       Impact factor: 1.228

8.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

Authors:  F R Rosendaal; T Koster; J P Vandenbroucke; P H Reitsma
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

  8 in total
  1 in total

1.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.